| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 419.196 | 90 |
| GSM780708 | Untreated after 4 days (C2_1) | 272.346 | 87 |
| GSM780709 | Untreated after 4 days (C3_1) | 282.551 | 87 |
| GSM780719 | Untreated after 4 days (C1_2) | 393.22 | 90 |
| GSM780720 | Untreated after 4 days (C2_2) | 257.94 | 86 |
| GSM780721 | Untreated after 4 days (C3_2) | 274.416 | 87 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 294.741 | 87 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 381.655 | 89 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 374.963 | 89 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 297.724 | 87 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 346.752 | 89 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 369.552 | 89 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 413.723 | 90 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 331.97 | 88 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 381.032 | 89 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 383.813 | 89 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 332.64 | 88 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 346.517 | 89 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 334.877 | 88 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 372.928 | 89 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 364.308 | 89 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 365.638 | 89 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 341.249 | 89 |